| # | Title | Journal | Year | Citations |
|---|
| 1 | Plasminogen Activators, Tissue Degradation, and Cancer | Advances in Cancer Research | 1985 | 2,307 |
| 2 | Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Advances in Cancer Research | 1997 | 1,570 |
| 3 | Signal Transduction through MAP Kinase Cascades | Advances in Cancer Research | 1998 | 1,551 |
| 4 | The Role of Glutathione and Glutathione S-Transferases in the Metabolism of Chemical Carcinogens and Other Electrophilic Agents | Advances in Cancer Research | 1979 | 1,058 |
| 5 | Tumor Angiogenesis | Advances in Cancer Research | 1985 | 1,042 |
| 6 | The Fgf Family of Growth Factors and Oncogenes | Advances in Cancer Research | 1992 | 1,016 |
| 7 | The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer | Advances in Cancer Research | 2010 | 980 |
| 8 | Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens | Advances in Cancer Research | 1989 | 978 |
| 9 | Carcinogenic Nitroso Compounds | Advances in Cancer Research | 1967 | 970 |
| 10 | Natural Cell-Mediated Immunity | Advances in Cancer Research | 1978 | 954 |
| 11 | Structural and Functional Diversity in the FGf Receptor Multigene Family | Advances in Cancer Research | 1992 | 883 |
| 12 | CD44: Structure, Function and Association with the Malignant Process | Advances in Cancer Research | 1997 | 858 |
| 13 | Alpha-Fetoprotein in Ontogenesis and its Association with Malignant Tumors | Advances in Cancer Research | 1971 | 815 |
| 14 | p53 and Human Cancer: The First Ten Thousand Mutations | Advances in Cancer Research | 1999 | 805 |
| 15 | Chapter 1: Interferons (IFNs) | Advances in Cancer Research | 1986 | 695 |
| 16 | Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation | Advances in Cancer Research | 1996 | 687 |
| 17 | Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting | Advances in Cancer Research | 2005 | 687 |
| 18 | The Biology of Cancer Invasion and Metastasis | Advances in Cancer Research | 1978 | 680 |
| 19 | Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer | Advances in Cancer Research | 1996 | 646 |
| 20 | Epoxides in Polycyclic Aromatic Hydrocarbon Metabolism and Carcinogenesis | Advances in Cancer Research | 1974 | 639 |
| 21 | Down-Regulation of the Antitumor Immune Response | Advances in Cancer Research | 1985 | 614 |
| 22 | TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer | Advances in Cancer Research | 2008 | 588 |
| 23 | Control of c-myc Regulation in Normal and Neoplastic Cells | Advances in Cancer Research | 1991 | 559 |
| 24 | The Sequential Analysis of Cancer Development | Advances in Cancer Research | 1980 | 521 |
| 25 | The Intricate Role of CXCR4 in Cancer | Advances in Cancer Research | 2014 | 496 |
| 26 | Tumor Angiogenesis | Advances in Cancer Research | 1974 | 471 |
| 27 | Alterations in DNA methylation: a fundamental aspect of neoplasia | Advances in Cancer Research | 1998 | 470 |
| 28 | Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis | Advances in Cancer Research | 2009 | 469 |
| 29 | Therapeutic Cancer Vaccines | Advances in Cancer Research | 2013 | 450 |
| 30 | Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors | Advances in Cancer Research | 1999 | 443 |
| 31 | Cellular Immunity Against Tumor Antigens | Advances in Cancer Research | 1969 | 438 |
| 32 | Myeloid-Derived Suppressor Cells | Advances in Cancer Research | 2015 | 419 |
| 33 | Histone Deacetylase Inhibitors | Advances in Cancer Research | 2004 | 410 |
| 34 | Metastatic Inefficiency | Advances in Cancer Research | 1990 | 409 |
| 35 | How Tumors Become Angiogenic | Advances in Cancer Research | 1996 | 408 |
| 36 | The Pathogenesis of Burkitt's Lymphoma | Advances in Cancer Research | 1990 | 399 |
| 37 | The myc Oncogene: omplex | Advances in Cancer Research | 2002 | 399 |
| 38 | 5-Methylcytosine, Gene Regulation, and Cancer | Advances in Cancer Research | 1983 | 396 |
| 39 | The Tumorigenicity of Human Embryonic Stem Cells | Advances in Cancer Research | 2008 | 390 |
| 40 | Criteria for Analyzing Interactions between Biologically Active Agents | Advances in Cancer Research | 1981 | 389 |
| 41 | Genetic Control Of Murine Viral Leukemogenesis | Advances in Cancer Research | 1973 | 384 |
| 42 | Lung Tumors in Mice: Application to Carcinogenesis Bioassay | Advances in Cancer Research | 1975 | 376 |
| 43 | Tumor Promoters and the Mechanism of Tumor Promotion | Advances in Cancer Research | 1980 | 368 |
| 44 | Natural Killer Cells and Cancer | Advances in Cancer Research | 2003 | 360 |
| 45 | Oncogene Activation in Chemical Carcinogenesis | Advances in Cancer Research | 1988 | 340 |
| 46 | The Intracisternal A-Particle Gene Family: Structure and Functional Aspects | Advances in Cancer Research | 1988 | 338 |
| 47 | Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation | Advances in Cancer Research | 1986 | 337 |
| 48 | Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification | Advances in Cancer Research | 2021 | 330 |
| 49 | Glycans and Cancer | Advances in Cancer Research | 2015 | 327 |
| 50 | p53-Dependent apoptosis pathways | Advances in Cancer Research | 2001 | 321 |
